Clinicopathological characteristics and value of HER2-low expression evolution in breast cancer receiving neoadjuvant chemotherapy

CONCLUSIONS: HR positive and HR negative HER2-low breast cancer exhibit different clinicopathological features, response to NAC and HER2 evolution after treatment.PMID:38159433 | DOI:10.1016/j.breast.2023.103666

Source: Breast - December 30, 2023 Category: Cancer & Oncology Authors: Yingbo Shao Huijuan Guan Zhifen Luo Yang Yu Yaning He Qi Chen Chaojun Liu Fangyuan Zhu Hui Liu Source Type: research